Zini Tanzi, Gina
 Distribuzione geografica
Continente #
EU - Europa 3.996
NA - Nord America 3.350
AS - Asia 750
SA - Sud America 26
AF - Africa 24
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.155
Nazione #
US - Stati Uniti d'America 3.327
DE - Germania 1.634
IT - Italia 702
CN - Cina 546
SE - Svezia 513
UA - Ucraina 285
GB - Regno Unito 224
FR - Francia 164
IE - Irlanda 150
PL - Polonia 107
FI - Finlandia 89
IN - India 69
BE - Belgio 33
TR - Turchia 32
ID - Indonesia 23
RU - Federazione Russa 20
JP - Giappone 15
ES - Italia 14
IR - Iran 13
NL - Olanda 13
BR - Brasile 12
CI - Costa d'Avorio 11
CA - Canada 10
CH - Svizzera 10
AT - Austria 8
MX - Messico 8
PT - Portogallo 8
HK - Hong Kong 7
AU - Australia 6
RO - Romania 6
KR - Corea 5
MY - Malesia 5
PH - Filippine 5
VN - Vietnam 5
AR - Argentina 4
CO - Colombia 4
IL - Israele 4
PE - Perù 4
BZ - Belize 3
CZ - Repubblica Ceca 3
NG - Nigeria 3
NO - Norvegia 3
SA - Arabia Saudita 3
SG - Singapore 3
TW - Taiwan 3
YE - Yemen 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
EE - Estonia 2
ET - Etiopia 2
GH - Ghana 2
GR - Grecia 2
JO - Giordania 2
LK - Sri Lanka 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
DK - Danimarca 1
DZ - Algeria 1
EU - Europa 1
IM - Isola di Man 1
IQ - Iraq 1
JM - Giamaica 1
KE - Kenya 1
MA - Marocco 1
MK - Macedonia 1
PK - Pakistan 1
PR - Porto Rico 1
QA - Qatar 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TZ - Tanzania 1
ZA - Sudafrica 1
Totale 8.155
Città #
Chandler 647
Ashburn 260
Jacksonville 194
San Mateo 174
Ann Arbor 169
Dublin 150
Dearborn 148
Nanjing 144
Nürnberg 105
Warsaw 96
Woodbridge 82
Cattolica 81
Beijing 80
Wilmington 78
Milan 71
Lawrence 66
Boston 62
Redmond 60
Fairfield 58
Bremen 55
New York 54
Houston 53
Nanchang 53
Rome 52
Seattle 51
Redwood City 50
Marseille 49
Lancaster 46
Munich 37
Los Angeles 36
Hangzhou 34
Brussels 31
Izmir 29
Norwalk 27
Leawood 25
Mountain View 25
Princeton 25
Shenyang 25
Zhengzhou 24
Boardman 23
Kunming 21
Jiaxing 19
Shanghai 19
Guangzhou 18
Augusta 17
Hebei 17
Tianjin 17
Hefei 16
Columbus 15
Cambridge 14
Falls Church 14
Pune 14
University Park 14
Helsinki 13
Chicago 12
Jakarta 12
Abidjan 11
Florence 11
Auburn Hills 10
Padova 10
São Paulo 9
Ypsilanti 9
Andover 8
Lanzhou 8
London 8
Sacramento 8
Simi Valley 8
Turin 8
Vienna 8
Genoa 7
San Diego 7
Cagliari 6
Changchun 6
Costa Mesa 6
Detroit 6
Fremont 6
Philadelphia 6
Washington 6
Bologna 5
Capaci 5
Indiana 5
Kansas City 5
Palermo 5
Parma 5
Phoenix 5
Torino 5
Toronto 5
Zanjan 5
Berlin 4
Changsha 4
Chengdu 4
Edinburgh 4
Hong Kong 4
Jinan 4
Kingston 4
Lima 4
Mexico City 4
Moscow 4
Nans-les-Pins 4
Ningbo 4
Totale 4.051
Nome #
MORFOLOGIA DELLE MALATTIE DEL SANGUE Verduci Editore 502
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 295
Allogeneic Umbilical Cord Blood Red Cell Concentrates: An Innovative Blood Product for Transfusion Therapy of Preterm Infants 268
Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD 244
Allogeneic Umbilical Cord Blood Red Cell Concentrates: An Innovative Blood Product for Transfusion Therapy of Preterm Infants 231
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 221
ICSH recommendations for the standardization of nomenclature and grading of peripheral blood cell morphological features 165
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 157
Defective WNT Signaling and Genetic Profile Of Endothelial Cells In Patients With Low Risk Myelodysplastic Syndromes Suggest a Contribution Of Vascular Niches To Myelodysplasia 153
Effect of dexamethasone on tracheobronchial aspirate fluid cytology and pulmonary mechanics in preterm infants 145
Weak D Type 4.2.2 (DAR1.2) in an African child: Serology and molecular characterization 140
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 139
Allogeneic umbilical cord blood red cell concentrates: an innovative blood product for transfusion therapy of preterm infants 135
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 129
Stability of complete blood count parameters with storage: toward defined specifications for different diagnostic applications 124
Hypoxia-inducible factor-1α(Pro-582-Ser) polymorphism prevents iron deprivation in healthy blood donors 121
Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD 121
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease 120
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease 120
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease 116
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 116
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 111
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy 110
Morphology of Blood Disorders 107
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 107
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 106
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease 101
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 99
Liquid chromatography-mass spectrometry measurement of leukotrienes in asthma and other respiratory diseases 98
TWO-GROUP STUDY OF MEDIAL MICROSCOPY AS A ROBUST TOOL TO HARMONIZE AND STANDARDIZE HAEMATOLOGICAL DIAGNOSIS 98
Analysis of bone marrow aspiration fluid using automated blood cell counters. 98
Allogeneic cord blood red cells for transfusion 96
Transfusion of very low birth weight neonates using allogeneic cord blood derived RBC units. 96
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 93
Adult and cord blood endothelial progenitor cells have different gene expression profiles and immunogenic potential 92
Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors 91
Poor mobilizer: A retrospective study on proven and predicted incidence according to GITMO criteria. 90
Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes. 86
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 86
Immature platelet fraction (IPF) in hospitalized patients with neutrophilia and suspected bacterial infection 79
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 79
Increased levels of solubile intercellular adhesion molecole-1, neutrophils and elastase in the lung of preterm infants with bronchopulmonary displasia. 77
Fechtner syndrome: report of a third family and literature review 76
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 76
Primary myelofibrosis: when the clone manifests with Rh phenotype splitting 75
The role of molecular typing and perfect match transfusion in sickle cell disease and thalassaemia: An innovative transfusion strategy 75
Poor mobilizer: a retrospective study on proven and predicted incidence according to GITMO criteria 74
Allogeneic umbilical cord blood red cell concentrates: An innovative blood product for transfusion therapy of preterm infants 72
Lymph node blast crisis in chronic myeloid leukemia mimicking T-immunoblastic lymphoma. 65
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 65
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 65
Fragmented red blood cells automated measurement is a useful parameter to exclude schistocytes on the blood film 64
Medicine use in pregnancy and public cord blood bank databases 60
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 60
Proposal for refining the definition of dysgranulopoiesis in acute myeloid leukemia and myelodysplastic syndromes 58
Stability of complete blood count parameters with storage: toward defined specifications for different diagnostic applications 58
Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response 56
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 55
Mononuclear cell collection for extracorporeal photopheresis: Concentrate characteristics for off-line UV-A irradiation procedure 55
ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes 54
Leukemia diagnosis: today and tomorrow 54
Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a “Gruppo Romano Mielodisplasie (GROM)” multicenter study 53
Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial 52
Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes? 51
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 51
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 51
A population-based study on myelodysplastic syndromes in the Lazio Region (Italy), medical miscoding and 11-year mortality follow-up: The Gruppo Romano-Laziale Mielodisplasie experience of retrospective multicentric registry 50
the concomitance of lymphoma and breast carcinoma in the bone 50
CELL-BY-CELL ASSESSMENT OF MEDIAL MICROSCOPY (MM) AS A BETWEEN-OBSERVER TOOL FOR HARMONIZATION AND PROFICIENCY TESTING (ON BEHALF OF WP10 LEUKEMIANET DIAGNOSIS MORPHOLOGICAL FACULTY) 49
Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD 48
Quality control initiative on the evaluation of the dysmegakaryopoiesis in myeloid neoplasms: Difficulties in the assessment of dysplasia 46
Comparison between multiparameter flow cytometry and WT1-RNA quantification in monitoring minimal residual disease in acute myeloid leukemia without specific molecular targets 45
Proposal for refining the definition of dysgranulopoiesis in acute myeloid leukemia and myelodysplastic syndromes 45
Diagnostics and prognostication of myelodysplastic syndromes 45
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia 45
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 42
Successful "on- demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors. 41
Innovation in hematology: Morphology and flow cytometry at the crossroads 40
The concomitance of lymphoma and breast carcinoma in the bone 40
Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance 38
Inline extracorporeal photopheresis: evaluation of cell collection efficiency 37
2021 update of the 2012 ICSH Recommendations for identification, diagnostic value, and quantitation of schistocytes: Impact and revisions 37
INTRODUCTION 36
ICSH: on board for new projects 34
Research in morphology and flow cytometry is at the heart of hematology 34
Adult and cord blood endothelial progenitor cells have different gene expression profiles and immunogenic potential 34
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 32
Morphology and immunophenotyping issues in the integrated diagnosis of hematologic disorders of elderly patients 31
Schistocytes 31
Dyserythropoiesis in the diagnosis of the myelodysplastic syndromes and other myeloid neoplasms: problem areas 31
Diagnostic Testing for Differential Diagnosis in Thrombotic Microangiopathies 28
Diagnostic Testing for Differential Diagnosis in Thrombotic Microangiopathies 18
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 2
Spontaneous resolution of “therapy-related myelodysplasia” occurred after treatment with CAR-T cells: All that glitters is not gold 2
Totale 8.248
Categoria #
all - tutte 24.851
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.851


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019277 0 0 0 0 0 0 0 0 0 80 126 71
2019/20201.292 207 113 88 100 94 157 97 62 72 85 126 91
2020/2021780 24 81 53 81 91 39 70 32 114 29 157 9
2021/2022957 82 91 22 49 77 37 30 163 36 52 132 186
2022/20231.876 214 261 146 289 139 234 78 169 238 28 51 29
2023/2024743 55 246 32 60 48 142 82 24 23 31 0 0
Totale 8.248